GeneID Lab - Advanced Molecular Diagnostics
General information
GeneID Lab - Advanced Molecular Diagnostics
Montvale
New Jersey
United States
http://www.geneidlab.com
Organization ID: 506582
Montvale
New Jersey
United States
http://www.geneidlab.com
Organization ID: 506582
Assertion criteria
Level: Assertion criteria provided
Summary of submissions to ClinVar
Total submissions: 48
Gene
| Gene | Submissions | Last Updated |
|---|---|---|
| AKAP9 | 1 | Jul 16, 2018 |
| BCKDHB | 2 | Nov 4, 2021 |
| BLM | 1 | Nov 4, 2021 |
| BRCA2 | 1 | Nov 4, 2021 |
| BRIP1 | 1 | Sep 11, 2017 |
| CA12 | 1 | Jul 16, 2018 |
| CDH1 | 1 | Sep 11, 2017 |
| CDH23 | 2 | Nov 4, 2021 |
| CHEK2 | 1 | Sep 11, 2017 |
| COL4A1 | 1 | Nov 4, 2021 |
| ELAC2 | 1 | Nov 4, 2021 |
| ELP1 | 1 | Jul 16, 2018 |
| FANCA | 1 | Nov 4, 2021 |
| GBA1 | 2 | Nov 4, 2021 |
| GBE1 | 1 | Jul 16, 2018 |
| GJB2 | 1 | Nov 4, 2021 |
| GJB3 | 1 | Jul 16, 2018 |
| GJB6 | 2 | Jul 16, 2018 |
| HEXA | 2 | Nov 4, 2021 |
| LOC106627981 | 2 | Nov 4, 2021 |
| MSH6 | 3 | Nov 4, 2021 |
| MUTYH | 1 | Sep 11, 2017 |
| MYO7A | 2 | Nov 4, 2021 |
| NBN | 3 | Nov 4, 2021 |
| PAH | 1 | Sep 11, 2017 |
| PALB2 | 1 | Nov 4, 2021 |
| PCDH15 | 3 | Jul 16, 2018 |
| PTCH1 | 1 | Nov 4, 2021 |
| RAD50 | 1 | Nov 4, 2021 |
| RECQL4 | 2 | Nov 4, 2021 |
| SCN5A | 1 | Nov 4, 2021 |
| SCNN1B | 1 | Jul 16, 2018 |
| TGFBR2 | 1 | Jul 16, 2018 |
| USH2A | 3 | Jul 16, 2018 |
| USH2A-AS2 | 1 | Sep 11, 2017 |
Condition
Testing in GTR
| Disease name | Number of tests |
|---|---|
| Acute lymphoid leukemia | 1 test |
| Adult-onset proximal spinal muscular atrophy, autosomal dominant | 1 test |
| Amyotrophic lateral sclerosis type 8 | 1 test |
| Aneurysm-osteoarthritis syndrome | 1 test |
| Aortic aneurysm, familial thoracic 4 | 1 test |
| Aortic aneurysm, familial thoracic 6 | 1 test |
| Aortic aneurysm, familial thoracic 7 | 1 test |
| Aplastic anemia | 2 tests |
| Arterial tortuosity syndrome | 1 test |
| Autosomal dominant childhood-onset proximal spinal muscular atrophy without contractures | 1 test |
| Autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome | 1 test |
| Autosomal dominant nonsyndromic hearing loss 13 | 1 test |
| Autosomal dominant nonsyndromic hearing loss 2A | 1 test |
| Autosomal dominant nonsyndromic hearing loss 2B | 1 test |
| Autosomal dominant nonsyndromic hearing loss 3A | 1 test |
| Autosomal dominant nonsyndromic hearing loss 3B | 1 test |
| Autosomal recessive nonsyndromic hearing loss 1A | 1 test |
| BAP1-related tumor predisposition syndrome | 2 tests |
| Baller-Gerold syndrome | 1 test |
| Bannayan-Riley-Ruvalcaba syndrome | 2 tests |
| Basal cell carcinoma, somatic | 1 test |
| Bloom syndrome | 1 test |
| Breast and colorectal cancer, susceptibility to | 3 tests |
| Breast lobular carcinoma | 2 tests |
| Breast-ovarian cancer, familial, susceptibility to, 1 | 4 tests |
| Breast-ovarian cancer, familial, susceptibility to, 2 | 3 tests |
| Breast-ovarian cancer, familial, susceptibility to, 3 | 2 tests |
| Breast-ovarian cancer, familial, susceptibility to, 4 | 2 tests |
| Bronchiectasis with or without elevated sweat chloride 1 | 1 test |
| Bronchiectasis with or without elevated sweat chloride 2 | 1 test |
| Bronchiectasis with or without elevated sweat chloride 3 | 1 test |
| CHEK2-related cancer predisposition | 3 tests |
| Canavan Disease, Familial Form | 1 test |
| Carcinoma of colon | 1 test |
| Carcinoma of pancreas | 1 test |
| Colorectal cancer, hereditary nonpolyposis, type 2 | 4 tests |
| Colorectal cancer, susceptibility to | 2 tests |
| Colorectal cancer, susceptibility to, 10 | 2 tests |
| Colorectal cancer, susceptibility to, 12 | 2 tests |
| Cowden syndrome 1 | 2 tests |
| Cystic fibrosis | 1 test |
| Decreased activity of the pyruvate dehydrogenase complex | 1 test |
| Ehlers-Danlos syndrome, type 4 | 1 test |
| Endometrial carcinoma | 1 test |
| Familial adenomatous polyposis 1 | 2 tests |
| Familial adenomatous polyposis 2 | 2 tests |
| Familial cancer of breast | 2 tests |
| Familial colorectal cancer | 3 tests |
| Familial dysautonomia | 1 test |
| Familial melanoma | 2 tests |
| Familial pancreatic carcinoma | 1 test |
| Familial thoracic aortic aneurysm and aortic dissection | 1 test |
| Fanconi anemia complementation group A | 1 test |
| Fanconi anemia complementation group C | 1 test |
| Fanconi anemia complementation group F | 1 test |
| Fanconi anemia complementation group G | 1 test |
| Fanconi anemia complementation group O | 2 tests |
| Fragile X syndrome | 1 test |
| Galactosemia | 1 test |
| Gaucher disease | 1 test |
| Generalized juvenile polyposis/juvenile polyposis coli | 2 tests |
| Glycogen storage disease, type II | 1 test |
| Glycogen storage disease, type IV | 1 test |
| Gorlin syndrome | 1 test |
| Hb SS disease | 1 test |
| Hereditary breast ovarian cancer syndrome | 4 tests |
| Hereditary cancer-predisposing syndrome | 4 tests |
| Hereditary diffuse gastric adenocarcinoma | 2 tests |
| Hereditary nonpolyposis colon cancer | 1 test |
| Infantile-onset X-linked spinal muscular atrophy | 1 test |
| Isolated hyperchlorhidrosis | 1 test |
| Jervell and Lange-Nielsen syndrome 1 | 1 test |
| Jervell and Lange-Nielsen syndrome 2 | 1 test |
| Juvenile Polyposis | 1 test |
| Leukemia, acute lymphoblastic, susceptibility to | 1 test |
| Li-Fraumeni syndrome 1 | 3 tests |
| Liddle syndrome 1 | 1 test |
| Liddle syndrome 2 | 1 test |
| Liddle syndrome 3 | 1 test |
| Loeys-Dietz syndrome 1 | 1 test |
| Loeys-Dietz syndrome 2 | 1 test |
| Long QT syndrome 1 | 1 test |
| Long QT syndrome 11 | 1 test |
| Long QT syndrome 3 | 1 test |
| Long QT syndrome 5 | 1 test |
| Long QT syndrome 6 | 1 test |
| Lung adenocarcinoma | 1 test |
| Lymphoma, non-Hodgkin, familial | 1 test |
| Lynch syndrome | 2 tests |
| Lynch syndrome 1 | 4 tests |
| Lynch syndrome 4 | 4 tests |
| Lynch syndrome 5 | 4 tests |
| Lynch syndrome 8 | 3 tests |
| Malignant melanoma of skin | 1 test |
| Malignant tumor of breast | 1 test |
| Maple syrup urine disease type 1A | 1 test |
| Maple syrup urine disease type 1B | 1 test |
| Maple syrup urine disease type 2 | 1 test |
| Marfan syndrome | 1 test |
| Melanoma, cutaneous malignant, susceptibility to, 2 | 2 tests |
| Melanoma, cutaneous malignant, susceptibility to, 3 | 1 test |
| Melanoma-pancreatic cancer syndrome | 2 tests |
| Mismatch repair cancer syndrome 1 | 4 tests |
| Mucolipidosis type IV | 1 test |
| Muir-Torré syndrome | 2 tests |
| Multiple endocrine neoplasia type 2A | 1 test |
| Multiple endocrine neoplasia type 2B | 1 test |
| Multiple myeloma | 1 test |
| Neoplasm | 2 tests |
| Neoplasm of the large intestine | 1 test |
| Niemann-Pick disease, type C1 | 1 test |
| Niemann-Pick disease, type C2 | 1 test |
| Nijmegen breakage syndrome-like disorder | 1 test |
| Non-Hodgkin lymphoma | 2 tests |
| Ornithine carbamoyltransferase deficiency | 1 test |
| PTEN hamartoma tumor syndrome | 2 tests |
| Pancreatic cancer, susceptibility to, 2 | 1 test |
| Pancreatic cancer, susceptibility to, 3 | 2 tests |
| Pancreatic cancer, susceptibility to, 4 | 2 tests |
| Papillary renal cell carcinoma type 1 | 2 tests |
| Pendred syndrome | 1 test |
| Peutz-Jeghers syndrome | 2 tests |
| Phenylketonuria | 1 test |
| Pheochromocytoma | 1 test |
| Polyposis syndrome, hereditary mixed, 1 | 1 test |
| Prostate cancer | 1 test |
| Prostate cancer susceptibility | 2 tests |
| Prostate cancer, hereditary, 2 | 2 tests |
| Proteus syndrome | 2 tests |
| Proteus-like syndrome | 2 tests |
| Pseudohypoaldosteronism, type IB1, autosomal recessive | 1 test |
| Pyruvate dehydrogenase E3 deficiency | 1 test |
| Rapadilino syndrome | 1 test |
| Renal cell carcinoma | 1 test |
| Rothmund-Thomson syndrome | 1 test |
| Spinal muscular atrophy | 1 test |
| Tay-Sachs disease | 1 test |
| Usher Syndrome, Type 1A | 1 test |
| Usher syndrome type 1 | 1 test |
| Usher syndrome type 1B | 1 test |
| Usher syndrome type 1C | 1 test |
| Usher syndrome type 1D | 1 test |
| Usher syndrome type 1F | 1 test |
| Usher syndrome type 2A | 1 test |
| Werdnig-Hoffmann disease | 1 test |
| alpha Thalassemia | 1 test |
| beta Thalassemia | 1 test |
